RevBio secures FDA approval to begin dental clinical trial for regenerative bone adhesive

2025-12-29

RevBio has received approval from the US Food and Drug Administration (FDA) to initiate a pilot dental clinical trial evaluating the safety and efficacy of

Global dental implants market forecast: Projected CAGR of 7.3% to reach $9.07bn by 2032

2025-11-13

The global dental implants market is projected to grow from an estimated value of $5.54bn in 2025 to $9.07bn by 2032, according to Coherent Market

Septodont Acquires Oraverse Anesthesia Reversal Drug

2011-03-21

Untitled Document LANCASTER, PENNSYLVANIA, MARCH 18, 2011: Septodont, the global leader in providing innovative, safe and effective solutions for dentistry worldwide, announces the purchase of